+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Antimicrobial Susceptibility Testing Market 2019-2023 - Product Image

Global Antimicrobial Susceptibility Testing Market 2019-2023

  • ID: 4790969
  • Report
  • May 2019
  • Region: Global
  • 124 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • MORE
Global Antimicrobial Susceptibility Testing Market: About this market

Antimicrobial susceptibility testing is used to determine the presence of bacteria and fungi in the body. The antimicrobial susceptibility testing market considers the application of antimicrobial susceptibility testing in clinical diagnostics, drug discovery and development, and others. Our analysis also considers the application of antimicrobial susceptibility testing in Asia, Europe, North America, and ROW. In 2018, the clinical diagnostics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing awareness of personalized medicine will play a significant role in the clinical diagnostics segment to maintain its market position. Also, our global antimicrobial susceptibility testing market looks at factors such as increased use of antimicrobial susceptibility testing by pharmaceutical companies, increasing the prevalence of infectious diseases, and increasing government initiatives. However, stringent government regulatory policies, challenges associated with antimicrobial susceptibility testing, and optimization of target product profiles may hamper the growth of the antimicrobial susceptibility testing industry over the forecast period.

Global Antimicrobial Susceptibility Testing: Overview

Increasing government initiatives

Governments across the world are undertaking various initiatives to create awareness among end-users about the effects of drugs on treating infections caused by pathogens. These initiatives are providing critical information to regulatory agencies, decision makers, and other end-users about the prevention of the incidences of diseases. For instance, India launched the National Programme on Containment of Antimicrobial Resistance as part of its 12th five-year plan to establish a laboratory-based AR surveillance system in the country and to create awareness among healthcare providers about AR. Such initiatives are accelerating the growth of the global antimicrobial susceptibility testing market at a CAGR of over 5% during the forecast period.

Increasing use of antibiograms

Antibiograms help in tracking local antibiotic resistance trends and improve the ability to avoiding suboptimal therapies and provide better patient care. They are also used as a tool in developing guidelines for empiric therapy and to make formulary decisions and monitor resistance rates. Despite high costs and complexities associated in the construction of antibiograms, their demand in the antimicrobial susceptibility testing industry is expected to increase over the forecast period.

Competitive Landscape

With the presence of several players, the global antimicrobial susceptibility testing market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several antimicrobial susceptibility testing companies, that include bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Merck KGaA, and Thermo Fisher Scientific Inc.

Also, the antimicrobial susceptibility testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Clinical diagnostics - Market size and forecast 2018-2023
  • Drug discovery and development - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Application - Market share 2018-2023 (%)
Exhibit 18: Comparison by application
Exhibit 19: Clinical diagnostics - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Clinical diagnostics - Year-over-year growth 2019-2023 (%)
Exhibit 21: Drug discovery and development - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Drug discovery and development - Year-over-year growth 2019-2023 (%)
Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by application
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Examples of infectious diseases caused by pathogenic microorganisms
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: bioMérieux SA - Vendor overview
Exhibit 47: bioMérieux SA - Business segments
Exhibit 48: bioMérieux SA - Organizational developments
Exhibit 49: bioMérieux SA - Geographic focus
Exhibit 50: bioMérieux SA - Key offerings
Exhibit 51: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 52: Bio-Rad Laboratories Inc. - Product segments
Exhibit 53: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 54: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 55: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 56: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 57: Danaher Corp. - Vendor overview
Exhibit 58: Danaher Corp. - Business segments
Exhibit 59: Danaher Corp. - Organizational developments
Exhibit 60: Danaher Corp. - Geographic focus
Exhibit 61: Danaher Corp. - Segment focus
Exhibit 62: Danaher Corp. - Key offerings
Exhibit 63: Merck KGaA - Vendor overview
Exhibit 64: Merck KGaA - Business segments
Exhibit 65: Merck KGaA - Organizational developments
Exhibit 66: Merck KGaA - Geographic focus
Exhibit 67: Merck KGaA - Segment focus
Exhibit 68: Merck KGaA - Key offerings
Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 70: Thermo Fisher Scientific Inc. - Business segments
Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 75: Validation techniques employed for market sizing
Exhibit 76: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • MORE
The following companies are recognised as the key players in the global antimicrobial susceptibility testing market: bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Merck KGaA, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing use of antibiograms.”

According to the report, one of the major drivers for this market is the increasing government initiatives.

Further, the report states that one of the major factors hindering the growth of this market is the optimization of target product profiles.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll